Related Experiment Video

Updated: Feb 27, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.1K

P53 and Protein Phosphorylation Regulate the Oncogenic Role of Epithelial Cell Transforming 2 (ECT2)

Yan Chen1, Ping Tian1, Yi Liu2

  • 1Department of Gastroenterology, Yidu Central Hospital of Weifang, Weifang, Shandong, China (mainland).

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|June 28, 2017
PubMed

Insights

Epithelial cell transforming 2 (ECT2) promotes gastric cancer (GC) progression and invasion. Its activity is regulated by p53 and phosphorylation, offering new therapeutic targets for advanced GC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Gastric cancer (GC) remains a leading cause of cancer death globally, with limited treatment options for advanced stages.
  • GC is characterized by significant heterogeneity, necessitating further research into its metastatic pathways.
  • Epithelial cell transforming 2 (ECT2) is upregulated in GC, but its precise role and signaling pathways are not fully understood.

Purpose of the Study:

  • To investigate the oncogenic mechanisms of Epithelial cell transforming 2 (ECT2) in gastric cancer (GC) cells.
  • To elucidate the upstream regulators and post-translational modifications of ECT2 in GC.
  • To explore ECT2's role in regulating GC cell proliferation, invasion, and epithelial-mesenchymal transition.

Main Methods:

  • Western blot analysis to compare ECT2 expression in GC cell lines (MKN1, MKN45).
  • Site-directed mutagenesis and transfections to study ECT2's oncogenic functions and signaling.
  • In vitro assays to assess the impact of ECT2 and its mutants on cell proliferation and invasion.

Main Results:

  • ECT2 expression was higher in MKN1 cells and modulated by wild-type and mutant p53.
  • ECT2 significantly promoted GC cell proliferation and invasion.
  • The phosphor-mimic mutant ECT2-T359D enhanced oncogenic activity and downregulated E-cadherin, indicating a role in epithelial-mesenchymal transition.
  • Phosphorylation of ECT2 at T359 is crucial for RhoA activation.

Conclusions:

  • p53 acts as a novel upstream regulator of ECT2 in gastric cancer.
  • Post-translational modifications, specifically phosphorylation at T359, are critical for ECT2's function in promoting GC progression.
  • ECT2's role in epithelial-mesenchymal transition highlights its significance in GC metastasis.

More Related Videos

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

2.8K
Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.7K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.2K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K